StockData
KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31

KAMADA LTD

Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 11, 2026
$7.61−0.15 (-1.93%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
21.7
Dividend yield
–

Margins

Share of revenue, fiscal years 2014 to 2025

Gross margin

42.3%+6.7 pts over 5 years

Operating margin

14.5%+0.1 pts over 5 years

Net margin

–